Abl Diagnostics (ABLD) | Stock Overview & Key Data
Abl Diagnostics Inc. | Small-cap | Healthcare
Abl Diagnostics Inc. | Small-cap | Healthcare
Abl Diagnostics Performance Comparison
Stock Range
Today's Range
Low: €4.48
High: €4.48
on October 3, 2025
52 Week Range
Low: €2.40
High: €8.10
on December 23, 2024
on March 6, 2025
All-Time High: €76.00 on October 31, 2022
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€86.8M
EPS
0.01
P/E Ratio (TTM)
535.00
Forward P/E
90.00
P/B Ratio
11.51
PEG Ratio
1.26
Div. Yield
0.92%
ROE
4.00%
Beta
-0.114
Debt to Equity
34.10
Financial Highlights
Profitability
Gross Margin
61.04%
Operating Margin
-6.06%
Profit Margin
4.86%
Returns and Earnings
Return on Assets (TTM)
-2.30%
Return on Equity (TTM)
4.00%
EBITDA
€6.9B
Net Income (TTM)
€285.2K
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.36
Quarterly Revenue Growth (YoY)
-10.30%
Quarterly Earnings Growth (YoY)
135.50%
Dividend Information
Last 12-Month Dividend
€0.05
Current Dividend Yield
0.92%
3-Year Average Dividend Yield
0.68%
3-Year Average Annual Dividend
€0.11
3-Year Total Dividends
€0.33
Ex-Dividend Date
June 27, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Abl Diagnostics ABLD | 86.82M Small-cap | -0.44% | -6.67% | -17.04% | -18.55% | 82.11% | 57.75% | -93.55% | 140.86% |
| Equasens EQS | 611.52M Mid-cap | -0.86% | -9.53% | -18.48% | 22.27% | -10.13% | -25.42% | -35.34% | -54.15% |
| Cegedim S.A CGM | 154.41M Mid-cap | -3.20% | 1.92% | -2.30% | 0.95% | -20.00% | -13.47% | -33.83% | -57.94% |
| Smaio S.A ALSMA | 39.66M Small-cap | 1.43% | 14.52% | 23.48% | 108.82% | 186.29% | 112.57% | 100.00% | 32.22% |
| Intrasense S.A ALINS | 15.75M Small-cap | -3.33% | 0.00% | 3.57% | 7.41% | 16.00% | 3.57% | -27.50% | -74.11% |
| Ama Corp Plc ALAMA | 15.59M Small-cap | 3.70% | 7.69% | 16.67% | 55.56% | 64.71% | 86.67% | -56.25% | -95.76% |
Ownership & Short Interest
Insider Ownership
99.64%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
89
Average 90-Day Volume
106
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ABLD's 52-week high and low?
- In the last 52 weeks, Abl Diagnostics reached a high of €8.10 (on March 6, 2025) and a low of €2.40 (on December 23, 2024).
- What is the market cap and P/E ratio for ABLD?
- Curious about Abl Diagnostics's size and valuation? Its market capitalization stands at 86.82M. When it comes to valuation, the P/E ratio (trailing twelve months) is 535.00, and the forward P/E (looking ahead) is 90.00.
- Does ABLD pay dividends? If so, what's the yield?
- Yes, Abl Diagnostics is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.92%, and the company has paid an average of €0.11 per share annually over the past 3 years.
- Who are Abl Diagnostics's main competitors or similar companies to consider before investing?
When looking at Abl Diagnostics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Equasens
EQS611.52M Healthcare Health Information Services -25.42% -35.34% Cegedim S.A
CGM154.41M Healthcare Health Information Services -13.47% -33.83% Smaio S.A
ALSMA39.66M Healthcare Health Information Services 112.57% 100.00% Intrasense S.A
ALINS15.75M Healthcare Health Information Services 3.57% -27.50% Ama Corp Plc
ALAMA15.59M Healthcare Health Information Services 86.67% -56.25% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Abl Diagnostics Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Abl Diagnostics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.00%, the Debt to Equity ratio from the most recent quarter is 34.10, and its Gross Profit Margin stands at 61.04%.
- What is the recent revenue and earnings growth for ABLD?
- Looking at Abl Diagnostics's growth, its revenue over the trailing twelve months (TTM) was €6M. Compared to the same quarter last year (YoY), quarterly revenue grew by -10.30%, and quarterly earnings saw a YoY growth of 135.50%.
- How much of ABLD stock is held by insiders and institutions?
- Wondering who owns Abl Diagnostics stock? Company insiders (like executives and directors) hold about 99.64% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.